glp 1 inhibitor diabetes GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome How GLP-1 Receptor Agonists Evolved

Jayaraman B, Nyachoti CM

Symptoms include: Dizziness Weakness Confusion Irritability To reduce the risk, users should monitor blood sugar , especially during the first few weeks of use, and consume adequate carbohydrates with each dose (DeFronzo et al., Diabetes Care )

As iron accumulation favors ROS generation and ferroptosis, it is plausible that the high iron exposure in the intestine is related to the tissues increased sensitivity to IR

doi:10.1038/s41430-020-0558-y Apostolakis, Michail et al

Whats Coming: The BALANCE Model (May 2026) The biggest development in Medicaid GLP-1 coverage is the BALANCE Model (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth), announced by CMS in December 2025

We further aimed for comparison of perioperative dynamics of GLP-1 and GLP-2 in the context of impaired liver regeneration of patients developing PHLF